Furthermore, YY1BM is involved in the progression of ESCC by inhibiting the interaction between YY1 and the androgen receptor (AR), leading to a decrease in the expression of eukaryotic elongation factor-2 kinase (eEF2K) through the AR signaling pathway. The gene discussed is AR; the disease is esophageal squamous cell carcinoma.